Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_assertion type Assertion NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_head.
- NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_assertion description "[Furthermore, analysis of leptin-treated breast tumors shows increased expression of Wnt1, pGSK3?, and vimentin along with higher nuclear accumulation of ?-catenin and reduced E-cadherin expression providing in vivo evidence for a previously unrecognized cross-talk between leptin and MTA1/Wnt signaling in epithelial-mesenchymal transition of breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_provenance.
- NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_assertion evidence source_evidence_literature NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_provenance.
- NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_assertion SIO_000772 22270359 NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_provenance.
- NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_assertion wasDerivedFrom befree-2016 NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_provenance.
- NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_assertion wasGeneratedBy ECO_0000203 NP955393.RA4jnewSJrApjzQod-9wOkf_C0ncfc_uAGaFikAK97BfY130_provenance.